Objective Neutralising pro-inflammatory interleukin-6 (IL-6) may effectively treat Crohn’s disease (CD). Effects of PF-04236921, an anti-IL-6 antibody, in adults with CD are reported. Results 247 ...
The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...
News Medical on MSN2d
Sweat fails to match blood in tracking inflammation after heart attacksResearchers found that while sweat biomarkers remain stable, plasma biomarkers show significant inflammatory changes after a ...
Medpage Today on MSN2d
Some Psoriasis Biologics Better Than Others for Preventing Progression to PsAPsoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...
The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...
Cancer Center's lymphoma specialist, Dr. Palomba, provides an in-depth look at how CAR T-cell therapy is evolving to offer ...
News Medical on MSN23h
Vitamin E significantly improves liver health in MASH patients, new study findsA 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...
Ruby Tsang summarises a recent longitudinal study of trajectories of inflammation in youth and risk of mental and ...
A phase 2 trial shows that olpasiran, an RNA-based therapy, reduces lipoprotein(a) [Lp(a)] levels by more than 95% in ...
A new study has discovered the reason why men tend to sustain more heart muscle damage following a heart attack than women: ...
A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback